5 - Contents

6-7 NEWS
Pfizer to acquire Seagen for $43bn; Merck signs $922m deal with Opko Health’s ModeX Therapeutics

8-9 NEWS
ABPI suspends Novo Nordisk; US government announces drugs subject to Medicare inflation rebates

10 CORONAVIRUS NEWS
JCVI recommends spring booster for highest risk

11 DERMATOLOGY NEWS
BMS’s Sotyktu approved by EC for plaque psoriasis

12 DARWIN'S MEDICINE
Some companies should be careful what they wish for

13 POLICY AND PUBLIC HEALTH
The greatest show on Earth

14 PROTECTING AGENCY HEALTH
Encouraging pharma and agency to work together

15 INNOVATIVE IMPACT BLOG
Why omnichannel is within your grasp

16-17 USING THE POWER OF DATA TO FUTURE-PROOF THE CLINICAL DEVELOPMENT INDUSTRY
With budgets being squeezed, economic disruption and the clinical development industry bracing itself for a new set of global challenges, these shifting headwinds are a continuation of the major disruption the sector has dealt with in recent years. It is important for biopharmaceutical companies, sponsors and CROs to apply learnings from data gathered over the past five years, and use it to redefine development to become more resilient to future challenges

18-19 SUPPLY CHAIN CHALLENGES IN 2023
Planning for potential disruption in 2023 will be crucial for pharmaceutical companies that wish to mitigate supply chain woes further down the line. This article looks at five of the biggest supply chain challenges pharmaceutical companies could face this year, from ongoing economic instability to climate risk

24-27 NEW BEGINNINGS – LEARNING THE LANGUAGE OF CHANGE
Behaviour change is a catalyst for improved performance and greater capabilities to face major healthcare challenges

28-29 THE IMPORTANCE OF AI IN IMPROVING PATIENT CARE
Behaviour change is a catalyst for improved performance and greater capabilities to face major healthcare challenges

32-33 PHARMA’S STRUGGLES WITH SOCIAL MEDIA
The current testing times for platforms like Twitter and Facebook should cause a moment of reflection

37 HEALTHCARE COMMS
Havas Health & You launches Archipelago; Medscape acquires Grupo SANED

38 IMPROVING OUTCOMES FOR PROSTATE CANCER PATIENTS
The importance of early diagnosis for prostate cancer, the most common cancer affecting men in the UK

April 2023